Skip to content

Interbody fusion in the treatment of cervicobrachial syndrome; a prospective trial of porous titanium cervical cages.

Interbody fusion in the treatment of cervicobrachial syndrome; a prospective trial of porous titanium cervical cages. - The EFFECT trial (Examination of Fast Fusion with EIT Cellular Titanium)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43762
Enrollment
50
Registered
2015-06-24
Start date
2015-09-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical herniated disc

Interventions

Anterior cervical discectomy with interbody fusion by implantation of 3-D trabecular titanium cage (EIT Cellular Titanium®).

Sponsors

neurochirurgie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age 18 75 years. * Radicular signs and symptoms in one or both arms (i.e., pain, paraesthesiae or paresis in a specific nerve root distribution) or symptoms and signs of myelopathy. * At least 8 weeks prior conservative treatment (i.e., physical therapy, pain medication). * Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3-C4 to C7-T1) in accordance with clinical signs and symptoms. * Written informed consent.

Exclusion criteria

Exclusion criteria: * Previous cervical surgery (either anterior or posterior) * Increased motion on dynamic studies (> 3 mm) * Neck pain only (without radicular or medullary symptoms) * Infection * Osteoporosis * Neoplasma or trauma of the cervical spine * Spinal anomaly (Klippel Feil, Bechterew, OPLL) * Severe mental or psychiatric disorder * Inadequate Dutch language * Planned (e)migration abroad in the year after inclusion . Pregnancy

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is improvement in the Neck and Disability Index (NDI) one year after surgery.

Secondary

MeasureTime frame
Secondary outcome measure is the temporal evaluation of bony fusion using dynamic lateral flexion-extension radiographs that will be quantitatively analysed. Other outcome measures include improvement in arm pain and neck pain (VAS), EuroQol-5D, patients' perceived recovery, and perioperative variables including operating time, blood loss, length of hospital stay, and adverse events.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)